Venture Capital

With promising new pipeline data and a major earnings report looming, Aclaris Therapeutics heads to two investor summits, placing its strategy on display.

Organon expands its Women's Health Accelerator to META, aiming to close health gaps and unlock a potential £1 trillion economic boost through digital innovation.

Tencent and HeritageSG launch an AI-powered robot guide, turning museum visits into interactive adventures and setting a new standard for heritage learning.

A new partnership between HAESL and HCLTech will transform engine repair with real-time data, setting a new standard for the aviation MRO industry.

Registration is open for Asia's massive food trade fair, where 180,000+ pros will discover the future of food and forge new global partnerships.

Vertical Aerospace and Marubeni target 2026 demo flights in Osaka, accelerating Japan's race to launch commercial electric air taxi services.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

Lam adds AI software and design automation leader Anirudh Devgan to its board, a strategic move to bridge chip design and manufacturing for the AI era.

During Super Bowl week, NAMI, Dan Marino, and NFL families are launching a major initiative to destigmatize mental health in sports and beyond.

A new bipartisan law injects vital funds into neuromuscular disease research, a victory driven by years of relentless patient advocacy. Here's what it means.

Following promising early results, RESTEM's Restem-L cell therapy enters a pivotal Phase 2/3 trial, aiming to transform treatment for IIM patients.

A new business coalition forms to protect NYC's Israeli tech sector, citing hostile policy shifts and rising antisemitism that threaten a vital economic engine.

A former Navy SEAL's tech startup marks one year of using AI to help veterans navigate the VA claims maze for free, taking on predatory firms and red tape.

A new partnership between Southern Research and Pathogenus Consulting combines US labs with a European network to fast-track treatments for global health threats.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

As AI’s energy crisis looms, Oxford spinout Lumai appoints a tech giant to bring its power-saving optical computing from the lab to the data center.

New online communities offer an 'emotional prescription' for patients, but can the platform's 'gold standard' model balance support with business?

With $105M in funding and stunning client results, Eudia's 'Augmented Intelligence' is transforming corporate legal from a cost center to a powerhouse.

With an $80M backlog and a new 'Buy' rating, cybersecurity firm Cycurion looks poised for growth. But can it overcome its volatile past and prove its worth?

Precision medicine firm Atropos Health joins NY's elite digital health startups, signaling a market shift toward scalable, data-driven healthcare solutions.